Come up with a name for your new list and we'll add to it:
Acuity Pharmaceuticals raised a round of funding on , . Investors include
Mitsubishi UFJ Capital.
OPKO Health, Inc. (Amex: OPK) today announced that a study published in the peer-reviewed journal Molecular Vision demonstrates that bevasiranib, its siRNA (small interfering RNA) agent is distributed…